Cargando…
Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064696/ https://www.ncbi.nlm.nih.gov/pubmed/37004035 http://dx.doi.org/10.1186/s12967-023-04040-7 |
| _version_ | 1785017952674775040 |
|---|---|
| author | Morales, Leah Simpson, Danny Ferguson, Robert Cadley, John Esteva, Eduardo Monson, Kelsey Chat, Vylyny Martinez, Carlos Weber, Jefrey Osman, Iman Kirchhof, Tomas |
| author_facet | Morales, Leah Simpson, Danny Ferguson, Robert Cadley, John Esteva, Eduardo Monson, Kelsey Chat, Vylyny Martinez, Carlos Weber, Jefrey Osman, Iman Kirchhof, Tomas |
| author_sort | Morales, Leah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10064696 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100646962023-04-01 Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival Morales, Leah Simpson, Danny Ferguson, Robert Cadley, John Esteva, Eduardo Monson, Kelsey Chat, Vylyny Martinez, Carlos Weber, Jefrey Osman, Iman Kirchhof, Tomas J Transl Med Correction BioMed Central 2023-03-31 /pmc/articles/PMC10064696/ /pubmed/37004035 http://dx.doi.org/10.1186/s12967-023-04040-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Morales, Leah Simpson, Danny Ferguson, Robert Cadley, John Esteva, Eduardo Monson, Kelsey Chat, Vylyny Martinez, Carlos Weber, Jefrey Osman, Iman Kirchhof, Tomas Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title | Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title_full | Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title_fullStr | Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title_full_unstemmed | Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title_short | Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| title_sort | correction: tumor immunogenomic signatures improve a prognostic model of melanoma survival |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064696/ https://www.ncbi.nlm.nih.gov/pubmed/37004035 http://dx.doi.org/10.1186/s12967-023-04040-7 |
| work_keys_str_mv | AT moralesleah correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT simpsondanny correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT fergusonrobert correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT cadleyjohn correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT estevaeduardo correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT monsonkelsey correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT chatvylyny correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT martinezcarlos correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT weberjefrey correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT osmaniman correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival AT kirchhoftomas correctiontumorimmunogenomicsignaturesimproveaprognosticmodelofmelanomasurvival |